We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI-Based Diagnosis System Identifies Malaria Parasites from Blood Smear Images

By LabMedica International staff writers
Posted on 15 May 2025

Malaria diagnosis has traditionally been performed manually via microscopic examination, a process that is not only time-consuming but also highly dependent on the expertise and accuracy of healthcare providers. More...

Factors such as fatigue, a shortage of skilled professionals, and the varying appearance of the parasite at different life stages often complicate accurate diagnoses. The application of artificial intelligence (AI) in healthcare continues to expand, including its potential to help diagnose tropical diseases like malaria, which remains a significant health threat in several regions worldwide.

Researchers at the National Research and Innovation Agency (BRIN, Jakarta, Indonesia) have developed an AI-based diagnostic tool to assist healthcare workers in identifying malaria parasites. This system analyzes microscopic images of thin and thick blood smears to detect signs of infection. To develop this tool, the researchers used a dataset of 1,388 blood smear microphotos collected from malaria-endemic areas in Indonesia. The dataset includes various malaria parasite types, such as Plasmodium falciparum, P. vivax, P. malariae, and P. ovale, along with one case of mixed infection and one negative sample.

Early testing of the AI-based diagnostic system has yielded promising results. The system was tested using 35 micrographs from real cases in malaria-endemic areas of Indonesia, covering 3,362 cells. The AI tool demonstrated a strong ability to identify malaria parasites, with a sensitivity of 84.37% in distinguishing between healthy and infected cells. The system achieved an accuracy value (F1-score) of 80.60% and a positive predictive value (PPV) of 77.14% in correctly identifying the parasite species and their stages. These results suggest that the system is highly reliable in distinguishing infected blood cells from healthy ones. This diagnostic system is also designed to facilitate mass blood surveys in the field, where a single smear may require observation of 500 to 1,000 erythrocytes or 200 leukocytes. AI can accelerate this process while maintaining accuracy.

Beyond improving efficiency, this system also opens up the possibility of remote diagnostics, making it especially relevant for use in underserved areas. Additionally, the system retains microscopic knowledge and expertise, aiding health workers with limited training. The researchers highlight the importance of addressing factors like dataset characteristics, data quality, model selection, and proper performance evaluation methods in the development of AI for biomedical applications. AI alone cannot function effectively—collaboration between computing experts and biomedical researchers is crucial for ensuring the reliability of such technologies. With the potential to significantly enhance diagnostic accuracy and improve healthcare delivery in malaria-endemic areas, the researchers are optimistic that AI will become a valuable partner in national malaria control efforts. The team is committed to further refining the system through extensive collaborative research and field trials.

Related Links:
BRIN


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.